
Care Delivery
The delivery of healthcare is something that Sam Regenstrief was particularly interested in. An inefficient healthcare experience is what led him and his wife Myrtie to found the institute.
Now its research scientists are exploring many avenues to improve care delivery. That includes decision support, symptom management, health communications and precision medicine. Regenstrief faculty are also experts in implementation science and quality measurement, analyzing both the success of interventions designed to improve care delivery and patient outcomes as well as success of the methods by which the intervention was implemented. Much of this work is conducted in partnership with the U.S. Department of Veterans Affairs, giving Regenstrief research scientists a national laboratory to conduct their research.
Many patients suffer from chronic symptoms such as pain, fatigue, insomnia or depression. Regenstrief has contributed to the development of scales and screeners to measure these symptoms, as well as interventions to manage them and improve the lives of those with long or short-term illnesses.
Regenstrief research also seeks to understand the dynamic of patient-provider relationships and the impact of technology, as well as the role of communication in patient outcomes. Handoffs and provider communication are another area of interest.
Implementation research is a relatively new field which examines research itself and how to meaningfully integrate it into practice. Regenstrief investigators and their teams devote their time and talent to understand and remove barriers to getting evidence-based research discoveries into healthcare settings. Regenstrief teams also use data to gain insights into the performance of healthcare systems, plans and interventions. Being able to evaluate care across different settings is the first step in being able to improve healthcare by identifying what works and what doesn’t.
Precision medicine combines prevention and treatment strategies, taking individual patient variables into account. This revolutionary approach to care has the potential to greatly enrich the amount of data available on a single patient and to leverage this data to improve quality of care and patient outcomes.
Related News & Stories
IBJ Honors Regenstrief research scientist with Heath Care Hero Award
The Indianapolis Business Journal (IBJ) honored Regenstrief Research Scientist Kurt Kroenke, M.D., MACP, as a Health Care Hero at a breakfast event today, March 9. This...
Study one of first to compare pain relief options for chronic low back pain patients already on opioids
To help patients manage chronic, often debilitating pain, physicians frequently prescribe medications as first line therapy, although treatment guidelines often call for non-pharmacologic approaches. One of...
Blood sugar monitoring devices pose wearability and use problems for older adults with diabetes and caregivers
A study conducted by Regenstrief Institute research scientists to examine the use, by older adults with Type 1 or Type 2 diabetes, of continuous use of...
Regenstrief Institute research scientists study online colorectal cancer risk calculators
Regenstrief Institute and Indiana University School of Medicine research scientists have conducted a study of online colorectal cancer risk calculators. Colorectal cancer remains the second leading...
Dr. Kurt Kroenke: Restraint in prescribing benzodiazepines
Dr. Kurt Kroenke cautions that benzodiazepines should not be used as first-line treatment for anxiety.
Benzodiazepine tightrope: Experts advocate provider and patient education, surveillance vs. strict governmental regulation
Anxiety disorders are among the most common and pervasive mental illnesses in the United States. Antidepressants and psychotherapy typically are the preferred treatment options, although benzodiazepines can...